We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
UNIFI
UFI
$134M
| $1.4M | ﹤0.01% |
50,642
-45
| -0.1% | -$1.09K |
|
2052
Winmark
WINA
$1.32B
| $1.39M | ﹤0.01% |
7,460
-1,860
| -20% | -$338K |
|
2053
Hackett Group
HCKT
$287M
| $1.39M | ﹤0.01% |
84,621
-54,620
| -39% | -$845K |
|
|
LBAI
2054
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.38M | ﹤0.01% |
79,389
-3,732
| -4% | -$57.8K |
|
2055
Argan
AGX
$8.37B
| $1.38M | ﹤0.01% |
25,924
-1,668
| -6% | -$80.4K |
|
2056
Dorian LPG
LPG
$1.96B
| $1.38M | ﹤0.01% |
105,324
-10,653
| -9% | -$141K |
|
|
FFWM
2057
DELISTED
First Foundation Inc
FFWM
| $1.38M | ﹤0.01% |
58,905
-3,356
| -5% | -$75K |
|
|
KBAL
2058
DELISTED
Kimball International
KBAL
| $1.38M | ﹤0.01% |
98,693
-12,106
| -11% | -$157K |
|
2059
Ingles Markets
IMKTA
$1.67B
| $1.38M | ﹤0.01% |
22,406
-1,799
| -7% | -$94.2K |
|
2060
Oil States International
OIS
$491M
| $1.38M | ﹤0.01% |
228,959
+1,649
| +0.7% | +$11.2K |
|
2061
Bristow Group
VTOL
$1.36B
| $1.38M | ﹤0.01% |
53,360
+2,388
| +5% | +$65K |
|
2062
Univest Financial
UVSP
$1.18B
| $1.38M | ﹤0.01% |
48,183
-2,822
| -6% | -$71.6K |
|
2063
Liberty Media Series A
FWONA
$23.6B
| $1.37M | ﹤0.01% |
37,556
+837
| +2% | +$31.2K |
|
2064
Tredegar Corp
TG
$310M
| $1.37M | ﹤0.01% |
91,416
+1,478
| +2% | +$23.6K |
|
|
TBRG
2065
DELISTED
TruBridge
TBRG
| $1.37M | ﹤0.01% |
44,839
+496
| +1% | +$15.3K |
|
2066
Ocular Therapeutix
OCUL
$2.02B
| $1.37M | ﹤0.01% |
83,526
-2,189
| -3% | -$42.2K |
|
|
KNL
2067
DELISTED
Knoll, Inc.
KNL
| $1.37M | ﹤0.01% |
82,993
-56,624
| -41% | -$927K |
|
2068
Park Aerospace
PKE
$819M
| $1.36M | ﹤0.01% |
103,144
+38,478
| +60% | +$542K |
|
2069
Washington Trust Bancorp
WASH
$741M
| $1.36M | ﹤0.01% |
26,281
-1,470
| -5% | -$71.3K |
|
|
EVOP
2070
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.35M | ﹤0.01% |
49,089
-1,330
| -3% | -$35.8K |
|
2071
ALX Oncology
ALXO
$290M
| $1.35M | ﹤0.01% |
18,275
+7,311
| +67% | +$575K |
|
2072
Frontline
FRO
$8.85B
| $1.34M | ﹤0.01% |
187,711
-7,935
| -4% | -$54.7K |
|
2073
Acco Brands
ACCO
$407M
| $1.34M | ﹤0.01% |
158,918
-8,714
| -5% | -$75K |
|
2074
Arcus Biosciences
RCUS
$3.64B
| $1.34M | ﹤0.01% |
47,773
-3,588
| -7% | -$125K |
|
|
HMHC
2075
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.33M | ﹤0.01% |
175,205
-9,839
| -5% | -$56.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.